My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

170.48 +14.02 (+8.96%)
Official Closing Price Updated: 7:00 PM EDT, Oct 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Trump-Pfizer Deal Pushes Health Care Stocks To Best Rally In 5 Years
Health care stocks rallied after Trump struck a drug pricing deal with Pfizer, offering major discounts and pausing pharma tariffs. 
Via Benzinga
Topics Government
Wednesday's session: top gainers and losers in the S&P500 index
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday. 
Via Chartmill
Which S&P500 stocks are moving on Wednesday?
Let's delve into the developments on the US markets in the middle of the day on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape
September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Masimo, Integra LifeSciences, CONMED, IQVIA, and Charles River Laboratories Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. The Trump administration is... 
Via StockStory
Topics Government World Trade
What's going on in today's session: S&P500 movers
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
Mr Wonderful Kevin O'Leary Says Bitcoin, Ethereum Enough To 'Capture The Promise' Of Crypto, Advises Against 'Irrelevant' Tokens
Renowned investor Kevin O’Leary expressed his belief on Wednesday that owning only Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH) can capture the majority of the cryptocurrency market’s volat 
Via Benzinga
Charles River Laboratories Announces Chief Financial Officer Transition
From Charles River Laboratories International, Inc.
Via Business Wire
Uncover the latest developments among S&P500 stocks in today's session.
Curious about the top performers within the S&P500 index one hour before the close of the markets on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive... 
Via Chartmill
Exploring the top movers within the S&P500 index during today's session.
Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer
From Charles River Laboratories International, Inc.
Via Business Wire
3 Unpopular Stocks That Concern Us
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
Breaking Down Charles River: 6 Analysts Share Their Views
 
Via Benzinga
This Thomson Reuters Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
 
Via Benzinga
2 Cash-Producing Stocks Worth Your Attention and 1 We Brush Off
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
1 S&P 500 Stock with Exciting Potential and 2 We Brush Off
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth,... 
Via StockStory
Topics Stocks
Charles River Enhances Cell Therapy Flex Platform through Collaboration with Akadeum Life Sciences
From Charles River Laboratories International, Inc.
Via Business Wire
Charles River Joins EASYGEN Consortium, Supports Development of Bedside CAR-T Manufacturing
From Charles River Laboratories International, Inc.
Via Business Wire
These S&P500 stocks are gapping in today's session
Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session. 
Via Chartmill
Is the Market Bullish or Bearish on Charles River?
 
Via Benzinga
1 Profitable Stock with Promising Prospects and 2 We Find Risky
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
Peter Thiel-Backed Bullish Shoots Up 11% After-Hours Following Blockbuster IPO
Shares of cryptocurrency exchange Bullish soared over 11% in Wednesday's after-hours trading following the company's successful Wall Street debut. 
Via Benzinga
In today's session, there are S&P500 stocks with remarkable trading volume.
Let's have a look at the S&P500 stocks with an unusual volume in today's session. 
Via Chartmill
Centene, RadNet, Evolent Health, Illumina, and Charles River Laboratories Shares Are Soaring, What You Need To Know
A number of stocks jumped in the morning session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. 
Via StockStory
Topics Bonds Economy Stocks
CRL Q2 Deep Dive: Flat Sales and Margin Pressures Offset by Demand Stabilization and Raised Outlook
Lab services company Charles River Laboratories (NYSE:CRL) reported Q2 CY2025 results topping the market’s revenue expectations, but sales were flat year on year at $1.03 billion. Its non-GAAP profit... 
Via StockStory
Topics World Trade
Charles River (CRL) Q2 EPS Jumps 11%
Via The Motley Fool
Charles River Sees Limited Impact From NIH Cuts, Tariffs, Drug Pricing
Charles River lifts earnings guidance after Q2 beat, citing biotech demand stability, solid DSA performance, and easing regulatory headwinds. 
Via Benzinga
Which S&P500 stocks are moving on Wednesday?
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
Charles River Laboratories (NYSE:CRL) Delivers Impressive Q2
Lab services company Charles River Laboratories (NYSE:CRL) reported Q2 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $1.03 billion. Its non-GAAP profit... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.